These limited data suggest the great suitability of serum FGF21 as a diagnostic biomarker of cancers, and also open the door for the speculation that an FGF21-driven liver-adipose tissue-tumor tissue axis is implicated in cancers. The gene discussed is FGF21; the disease is neoplasm.